| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/18/1994 | EP0596881A1 Expression in non-tumoral human lymphoblastoid lines with an integrative vector. |
| 05/18/1994 | EP0502872B1 Methods and materials for expression of human plasminogen variant |
| 05/18/1994 | EP0380495B1 Serum free media for the growth of insect cells and expression of products thereby |
| 05/18/1994 | EP0335899B1 Immunoaffinity purification system |
| 05/18/1994 | EP0328552B1 Thrombin derived polypeptides, compositions and methods for use |
| 05/18/1994 | EP0283475B1 Enhanced secretion of heterologous proteins by hosts using substituted promoters |
| 05/18/1994 | EP0248819B1 Recombinant fibroblast growth factors |
| 05/17/1994 | US5312801 Culture of plants from embryos |
| 05/17/1994 | US5312751 Hybridoma producing a monoclonal antibody specific for an antigen of the stratum corneum of human epidermis |
| 05/17/1994 | US5312740 Process for producing taxol by cell culture of taxus species |
| 05/17/1994 | US5312736 DNA-sequence encoding the analog; expression vector containing the sequence; transformed or transfected microorganism or cell line comprising the vector; culture preparation of analog; drug including analog |
| 05/17/1994 | US5312732 Hormone receptor compositions and methods |
| 05/17/1994 | CA1329561C Potyvirus coat protein genes and plants transformed therewith |
| 05/14/1994 | CA2102673A1 Expression vectors for bovine trypsin and trypsinogen and host cells transformed therewith |
| 05/13/1994 | CA2102848A1 Altered affinity polypeptides of metal chelate binding antibodies |
| 05/11/1994 | WO1994010569A1 METHODS AND COMPOSITIONS FOR THE DETECTION OF SOLUBLE β-AMYLOID PEPTIDE |
| 05/11/1994 | WO1994010338A1 Nuclear hormone receptor-interacting polypeptides and related molecules and methods |
| 05/11/1994 | WO1994010331A1 Angiogenesis inhibitory antibodies |
| 05/11/1994 | WO1994010313A2 Interferon tau compositions and methods of use |
| 05/11/1994 | WO1994010309A1 Novel p-selectin ligand protein |
| 05/11/1994 | WO1994010307A1 Transcription factor dp-1 |
| 05/11/1994 | WO1994010305A1 Transformed endothelial cells |
| 05/11/1994 | WO1994010303A1 Multidrug resistance gene |
| 05/11/1994 | WO1994010301A1 TNF-α RIBOZYMES AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-α RIBOZYMES |
| 05/11/1994 | WO1994010294A1 Human monoclonal antibodies to human parvovirus and methods of making and using thereof |
| 05/11/1994 | WO1994010293A1 Thymic stromal cell cultures for t-cell differentiation |
| 05/11/1994 | WO1994010292A1 Biological factors and neural stem cells |
| 05/11/1994 | WO1994010291A1 CULTURE CELLS OF $i(QUILLAJA SP.) |
| 05/11/1994 | WO1994010288A2 Medium-chain thioesterases in plants |
| 05/11/1994 | WO1994010203A2 Op-3-induced morphogenesis |
| 05/11/1994 | WO1994010201A1 Peptides and vaccines derived from nematode tubulin |
| 05/11/1994 | WO1994010189A1 Plant fatty acid synthases |
| 05/11/1994 | WO1994010187A1 COMPOSITIONS AND METHODS FOR MODIFYING THE REGULATORY ACTIVITY OF TGF-$g(b) |
| 05/11/1994 | WO1994009828A1 Dna encoding a human serotonin receptor (5-ht4b) and uses thereof |
| 05/11/1994 | WO1994009820A1 Prostate-specific membrane antigen |
| 05/11/1994 | WO1994009803A1 Enhancement of xenograft tolerance and porcine cytokines therefor |
| 05/11/1994 | WO1994009760A1 Biodegradable polymers for cell transplantation |
| 05/11/1994 | WO1994006919A3 Stably-transformed mammalian cells expressing a regulated, inflammatory cyclooxygenase |
| 05/11/1994 | EP0596479A2 Basophil-binding monoclonal antibody, method for separation of basophils, method for chemical mediator release from basophils, and method for testing release of basophil-derived chemical mediators |
| 05/11/1994 | EP0596355A1 Method for the assay of enkephalinase |
| 05/11/1994 | EP0596315A2 A method of attaching dialdehyde starch to a surface and products produced by that method |
| 05/11/1994 | EP0595981A1 CALLASE-RELATED DNAs AND THEIR USE IN ARTIFICIAL MALE STERILITY |
| 05/11/1994 | EP0595935A1 Papilloma virus vaccine |
| 05/11/1994 | EP0595896A1 Transgenic plants producing polyhydroxyalkanoates |
| 05/11/1994 | EP0595873A1 Cytosine deaminase negative selection system for gene transfer techniques and therapies |
| 05/11/1994 | EP0595838A1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
| 05/11/1994 | EP0595798A1 Bispecific heteroantibodies with dual effector functions |
| 05/11/1994 | EP0429478B1 Expression cassette for plants |
| 05/11/1994 | CN1086543A CDNA clones coding for polypepstides exhibiting human granulocyte macrophage and eosinophie cellular growth |
| 05/11/1994 | CA2148368A1 Tnf-.alpha. ribozymes and degradation resistant mrna derivatives linked to tnf-.alpha. ribozymes |
| 05/11/1994 | CA2148358A1 Plant fatty acid synthases |
| 05/11/1994 | CA2148258A1 Transcription factor dp-1 |
| 05/11/1994 | CA2148244A1 Angiogenesis inhibitory antibodies |
| 05/11/1994 | CA2148119A1 Interferon tau compositions and methods of use |
| 05/11/1994 | CA2147756A1 Peptides and vaccines derived from nematode tubulin |
| 05/11/1994 | CA2147754A1 Compositions and methods for modifying the regulatory activity of tgf- .beta. |
| 05/11/1994 | CA2147617A1 Medium-chain thioesterases in plants |
| 05/11/1994 | CA2147598A1 Op-3-induced morphogenesis |
| 05/11/1994 | CA2147480A1 Cultured cells of quillaja sp. |
| 05/11/1994 | CA2143489A1 Transformed endothelial cells |
| 05/10/1994 | US5310883 Stabilized versions of glu-3,5-basic FGF having eliminated disulfide scrambled forms; wound healing agents; promoters of angiogenesis, neutrotropism and chemotaxis |
| 05/10/1994 | US5310673 Mass propagation through shoot primordia and regeneration of plants from protoplasts of shoot primordia |
| 05/10/1994 | US5310672 Antitumor agents |
| 05/10/1994 | US5310671 Vector for foreign dna and sequence for regulating thegene; vaccines |
| 05/10/1994 | US5310669 Biochemical immobilazion |
| 05/10/1994 | US5310662 Receptors: their identification, characterization, preparation and use |
| 05/06/1994 | CA2108608A1 Method of attaching dialdehyde starch to a surface and products produced by that method |
| 05/04/1994 | EP0594881A1 Expression vectors and their application in the construction of HIV-resistant human cells for therapeutic uses |
| 05/04/1994 | EP0594879A1 Cathepsin L-specific monoclonal antibodies, hybridomas for producing the same and a method of using the same |
| 05/04/1994 | EP0594764A1 Hematopoietic growth factor derived from t lymphocytes and methods of use therefor |
| 05/04/1994 | EP0594743A1 Continuous cell line and vaccine against avian coccidia |
| 05/04/1994 | EP0594732A1 Humanized antibody against cd18 |
| 05/04/1994 | EP0594725A1 Yolk sac stem cells |
| 05/04/1994 | EP0594669A1 NOVEL GROWTH FACTOR-RESPONSIVE PROGENITOR CELLS WHICH CAN BE PROLIFERATED $i(IN VITRO) |
| 05/04/1994 | EP0594610A1 PROTEIN D - AN IgD-BINDING PROTEIN OF HAEMOPHILUS INFLUENZAE |
| 05/04/1994 | EP0594576A1 Immunoassays for and monoclonal antibodies to prothrombin activation peptides and their degradation products |
| 05/04/1994 | EP0439601B1 Composition containing a b epitope of the envelope glycoprotein of a retrovirus and a t epitope of a distinct protein from this virus |
| 05/04/1994 | CN1086265A Method for preparing natural interleukin-II |
| 05/04/1994 | CN1086262A New DNA sequences |
| 05/04/1994 | CN1086142A Vaccines |
| 05/03/1994 | US5308764 Two distinct cell types, cancerous and normal cells |
| 05/03/1994 | US5308763 Digestion of cells, filtration, removal of cell aggregates and plating cells in nutrients |
| 05/03/1994 | US5308757 Biological cell treatment method and apparatus |
| 05/03/1994 | US5308750 Binders for hepatitis C virus and hybridomas and antigens |
| 05/03/1994 | US5308626 Lymphokine activated effector cells for antibody-dependent cellular cytotoxicity (ADCC) treatment of cancer and other diseases |
| 04/28/1994 | WO1994009160A1 Method of inhibiting replication of hyperproliferative cells |
| 04/28/1994 | WO1994009150A1 Monoclonal antibodies to prostate cells |
| 04/28/1994 | WO1994009149A1 Monoclonal antibody |
| 04/28/1994 | WO1994009137A1 Antibodies against type 2 tumor necrosis factor receptor |
| 04/28/1994 | WO1994009136A1 Recombinant humanized anti-cytomegalovirus antibodies |
| 04/28/1994 | WO1994009135A1 Cyclin complex rearrangement and uses related thereto |
| 04/28/1994 | WO1994009134A2 Modified ciliary neurotrophic factors |
| 04/28/1994 | WO1994009131A1 Recombinant specific binding protein |
| 04/28/1994 | WO1994009130A1 Polypeptides (5ht2c) having a serotoninergic receptor activity and uses thereof |
| 04/28/1994 | WO1994009120A1 Retroviral mediated transfer of the human multiple drug resistance gene |
| 04/28/1994 | WO1994009119A1 Remyelination using neural stem cells |
| 04/28/1994 | WO1994009118A1 Immortalized human chondrocytes |
| 04/28/1994 | WO1994009117A1 Direct selection of cells by secretion product |
| 04/28/1994 | WO1994009116A1 Cho cells expressing human endothelin receptors |
| 04/28/1994 | WO1994008598A1 Liver reserve cells |